BLFS
Income statement / Annual
Last year (2025), Biolife Solutions Inc's total revenue was $96.21 M,
an increase of 16.97% from the previous year.
In 2025, Biolife Solutions Inc's net income was -$12.13 M.
See Biolife Solutions Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$96.21 M |
$82.25 M |
$68.02 M |
$76.24 M |
$119.16 M |
$48.09 M |
$27.37 M |
$19.74 M |
$11.02 M |
$8.23 M |
| Cost of Revenue |
$34.10 M
|
$28.58 M
|
$26.70 M
|
$29.33 M
|
$83.11 M
|
$23.68 M
|
$9.84 M
|
$6.22 M
|
$4.28 M
|
$3.45 M
|
| Gross Profit |
$62.12 M
|
$53.67 M
|
$41.32 M
|
$46.91 M
|
$36.05 M
|
$24.41 M
|
$17.53 M
|
$13.53 M
|
$6.75 M
|
$4.78 M
|
| Gross Profit Ratio |
0.65
|
0.65
|
0.61
|
0.62
|
0.3
|
0.51
|
0.64
|
0.69
|
0.61
|
0.58
|
| Research and Development Expenses |
$7.57 M
|
$7.91 M
|
$18.80 M
|
$14.80 M
|
$11.82 M
|
$6.72 M
|
$4.12 M
|
$1.30 M
|
$1.19 M
|
$2.03 M
|
| General & Administrative Expenses |
$45.52 M
|
$40.54 M
|
$42.79 M
|
$33.26 M
|
$34.10 M
|
$14.61 M
|
$8.89 M
|
$5.95 M
|
$4.52 M
|
$4.59 M
|
| Selling & Marketing Expenses |
$9.85 M
|
$9.61 M
|
$11.38 M
|
$11.67 M
|
$14.00 M
|
$6.41 M
|
$4.70 M
|
$2.62 M
|
$2.09 M
|
$3.01 M
|
| Selling, General & Administrative Expenses |
$55.37 M
|
$50.15 M
|
$54.17 M
|
$44.93 M
|
$48.09 M
|
$21.02 M
|
$13.59 M
|
$8.57 M
|
$6.61 M
|
$7.60 M
|
| Other Expenses |
$0.00
|
$2.74 M
|
-$14.44 M
|
-$6.89 M
|
-$417.00 K
|
$6.35 M
|
$1.41 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$62.94 M
|
$60.80 M
|
$58.52 M
|
$52.83 M
|
$59.50 M
|
$34.09 M
|
$19.12 M
|
$9.86 M
|
$7.80 M
|
$9.63 M
|
| Cost And Expenses |
$97.30 M
|
$89.38 M
|
$85.22 M
|
$82.16 M
|
$149.81 M
|
$54.33 M
|
$27.59 M
|
$16.08 M
|
$12.08 M
|
$13.08 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$58.00 K
|
$506.00 K
|
$281.00 K
|
$1.00 K
|
$2.42 K
|
| Interest Expense |
$2.71 M
|
$719.00 K
|
$1.81 M
|
$687.00 K
|
$485.00 K
|
$18.00 K
|
$5.00 K
|
$5.00 K
|
$455.00 K
|
$318.39 K
|
| Depreciation & Amortization |
$4.69 M
|
$8.66 M
|
$12.30 M
|
$7.58 M
|
$12.87 M
|
$5.07 M
|
$1.80 M
|
$338.00 K
|
$339.00 K
|
$368.10 K
|
| EBITDA |
$3.61 M |
$1.53 M |
-$7.10 M |
-$3.10 M |
-$17.78 M |
$1.48 M |
$2.57 M |
-$24.66 M |
-$1.79 M |
-$7.35 M |
| EBITDA Ratio |
0.04
|
0.02
|
-0.1
|
-0.04
|
-0.15
|
0.03
|
0.09
|
-1.25
|
-0.16
|
-0.89
|
| Operating Income Ratio |
-0.01
|
-0.09
|
-1.04
|
-0.08
|
-0.26
|
-0.07
|
-0.01
|
0.19
|
-0.1
|
-0.59
|
| Total Other Income/Expenses Net |
-$11.00 M
|
-$4.30 M
|
$7.18 M
|
$1.08 M
|
$1.62 M
|
$4.96 M
|
-$2.98 M
|
-$28.67 M
|
-$1.46 M
|
-$3.19 M
|
| Income Before Tax |
-$12.08 M
|
-$11.43 M
|
-$12.22 M
|
-$4.85 M
|
-$29.03 M
|
-$1.28 M
|
-$3.20 M
|
-$25.01 M
|
-$2.52 M
|
-$8.04 M
|
| Income Before Tax Ratio |
-0.13
|
-0.14
|
-0.18
|
-0.06
|
-0.24
|
-0.03
|
-0.12
|
-1.27
|
-0.23
|
-0.98
|
| Income Tax Expense |
$49.00 K
|
-$38.00 K
|
-$64.00 K
|
-$5.24 M
|
-$20.12 M
|
-$3.26 M
|
-$1.54 M
|
$0.00
|
$0.00
|
$1.62 M
|
| Net Income |
-$12.13 M
|
-$20.18 M
|
-$66.43 M
|
-$139.81 M
|
-$8.91 M
|
$1.98 M
|
-$1.66 M
|
-$25.01 M
|
-$2.52 M
|
-$6.88 M
|
| Net Income Ratio |
-0.13
|
-0.25
|
-0.98
|
-1.83
|
-0.07
|
0.04
|
-0.06
|
-1.27
|
-0.23
|
-0.84
|
| EPS |
-0.25 |
-0.44 |
-1.52 |
-3.29 |
-0.23 |
0.0667 |
-0.0851 |
-1.56 |
-0.21 |
-0.54 |
| EPS Diluted |
-0.25 |
-0.44 |
-1.52 |
-3.29 |
-0.23 |
0.07 |
-0.0852 |
-1.56 |
-0.21 |
-0.54 |
| Weighted Average Shares Out |
$47.75 M
|
$46.07 M
|
$43.72 M
|
$42.48 M
|
$38.50 M
|
$27.31 M
|
$19.46 M
|
$16.26 M
|
$13.26 M
|
$12.64 M
|
| Weighted Average Shares Out Diluted |
$48.65 M
|
$46.07 M
|
$43.72 M
|
$42.48 M
|
$38.50 M
|
$27.31 M
|
$19.46 M
|
$16.26 M
|
$13.26 M
|
$12.64 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
